Check out your Company Bowl for anonymous work chats.
We’re launching in Europe on May 16th! Evolus is proud to announce the upcoming commercial launch of Estyme®, our injectable hyaluronic acid gel collection, marking our entry into the international dermal filler market. This milestone represents a new phase of growth as we continue to expand our multi-product portfolio beyond neurotoxins and scale our global hashtag#performancebeauty company. Welcome to the future of #aesthetics! $EOLS #Evolus #EvolveWithUs #Estyme
Today, we reported our Q1 2026 financials and provided business updates. Read the release and access the conference call link here: https://lnkd.in/gnq7pZC4 $EOLS #EvolveWithUs #PerformanceBeauty #MedicalAesthetics
Rome set the stage, our people delivered! An unforgettable Evolus International Sales Meeting and the perfect kickoff to 2026. Big ideas, strong alignment, and a global team ready to win! Ready…Set…GO! #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics
IMCAS 2026 was a massive success for Evolus as we introduced Estyme® to the European aesthetic community in partnership with SYMATESE. The congress represented a key step forward in our global HA strategy, bringing science, education, and clinical experience together around our newest portfolio product. Across the meeting, physicians engaged with the scientific foundations of the product, including Cold-X™ technology and the extensive international clinical program supporting it. Evolus and Symatese delivered a strong educational presence throughout the congress: · An expert-led symposium featuring Dr. Natasha Berridge, Dr. Benji Dhillon, Dr. David Eccleston, Dr. Maurizio Cavalini, Dr. Jeremy Green, Dr. Rui Avelar, MD, and Benjamin HERBAGE · A live injection demonstration focused on Estyme® Lips with Dr. Sophie Converset-Viethel and Dr. Docteur Philippe Kestemont · A CME-accredited lecture by Dr. Jeremy Green centered on Estyme® Sculpt Discussions during La Tribune sessions brought together industry perspectives from David Moatazedi, President & CEO of Evolus, alongside Benjamin HERBAGE, Deputy Managing Director at Symatese, and Laurent Brones, Director of Communication & Alliances at Symatese. IMCAS reinforced Evolus’ commitment to advancing medical aesthetics through #innovation, partnership, and education as we continue to expand across Europe. #Evolus #EvolveWithUs #IMCAS2026 #MedicalAesthetics
Congratulations to our General Counsel, Jeffrey Plumer, on being recognized in the Orange County Business Journal’s OC 500, honoring the region’s most influential business leaders. Jeff’s leadership, integrity, and legal expertise continue to make a lasting impact on Evolus and our mission to redefine the hashtag#aesthetics industry. Congratulations, Jeff, on this well-deserved recognition! #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics
We’re thrilled to share that Evolus has been included in the Deloitte Technology Fast 500 for 2025, marking our third consecutive year on the list! This continued recognition underscores the strength of our team, the momentum of our business, and our unwavering commitment to innovation in hashtag#performancebeauty. Thank you to our customers, consumers, and partners for your continued trust and collaboration. Together, we’re redefining hashtag#aesthetics and shaping the future of our industry. https://lnkd.in/gqiQ2uMG #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics
Evolus reports 3rd Quarter 2025 Earnings. Read the release : https://lnkd.in/eSjVQ4DC $EOLS #EvolveWithUs #PerformanceBeauty #MedicalAesthetics
Today we announced the appointment of Tatjana Mitchell as Chief Financial Officer of Evolus. With more than 20 years of finance leadership across retail, consumer, data, and technology-driven businesses, Tatjana brings a strong track record of driving growth and operational discipline. Her experience will be instrumental as we continue to expand our portfolio and strengthen our leadership in performance beauty. Welcome Tatjana! Read the press release: https://lnkd.in/e8ZbaWqU hashtag#Evolus hashtag#EvolveWithUs hashtag#PerformanceBeauty hashtag#MedicalAesthetics
Evolus reported our Q2 2025 financials and provided business updates. Read the release and access the conference call link here: https://lnkd.in/e_Jcw3sU $EOLS #EvolveWithUs #PerformanceBeauty #MedicalAesthetics
#PerformanceBeauty is all about results. Today, we announced results of the independent JAMA Dermatology study where our toxin was a top performer among the leading hashtag#neurotoxins! Here's what stood out: • Fast Onset of Action • Strong Peak Effect • Long Duration of Effect Read the full release here: https://lnkd.in/ew9pRZcv hashtag#Evolus hashtag#EvolveWithUs hashtag#PerformanceBeauty hashtag#MedicalAesthetics
